MARKET

MED

MED

Medifast
NYSE
74.81
-0.15
-0.20%
After Hours: 74.81 0 0.00% 16:02 12/08 EST
OPEN
74.89
PREV CLOSE
74.96
HIGH
75.94
LOW
74.33
VOLUME
117.83K
TURNOVER
0
52 WEEK HIGH
131.42
52 WEEK LOW
61.94
MARKET CAP
814.88M
P/E (TTM)
6.82
1D
5D
1M
3M
1Y
5Y
Are Investors Undervaluing Medifast, Inc. (NYSE:MED) By 47%?
Medifast's estimated fair value is US$140 based on 2 Stage Free Cash Flow to Equity Current share price of US$74.81 suggests Medifast is potentially 47% undervalued. We use the Discounted Cash Flow (DCF) model to estimate the value of the company. The method takes the expected future cash flows and discounts them to their present value. Medifold, Inc. Now has a valuation of US $140.
Simply Wall St · 9h ago
Here's How Much You'd Have If You Invested $1000 in Medifast a Decade Ago
NASDAQ · 2d ago
Weekly Report: what happened at MED last week (1127-1201)?
Weekly Report · 5d ago
Validea Benjamin Graham Strategy Daily Upgrade Report - 11/28/2023
NASDAQ · 11/28 11:13
Weekly Report: what happened at MED last week (1120-1124)?
Weekly Report · 11/27 09:18
Medifast (MED) Poised on OPTAVIA ACTIVE Line Amid Cost Woes
NASDAQ · 11/24 16:03
Medifast: Good On Paper, But A Slowdown In Sales Is Very Worrisome
Medifast has strong financials with a healthy cash position and no debt. Med's sales have plummeted due to tough macroeconomic conditions and competition from weight loss drugs. The company's efficiency and profitability metrics are impressive, but the company's high-priced products may deter customers. Medifast's business model is questionable and the company has a low pe ratio.
Seeking Alpha · 11/24 10:46
Is It Too Late To Consider Buying Medifast, Inc. (NYSE:MED)?
Medifast, inc. (nyse:med) saw significant share price movement in recent months. The small-cap is currently trading at a price of us$67.50 on the nyse. Medifast is expected to deliver a negative earnings growth in the next few years. The company is trading below the industry average, but is still undervalued. Let's take a look at the company's outlook and value.
Simply Wall St · 11/21 10:20
More
About MED
Medifast, Inc. (Medifast) is a health and wellness company. The Company sells a variety of weight loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. Medifast’s product line includes more than 65 consumable options, including, but not limited to, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. OPTAVIA coaches also counsel their customers on how to develop healthy habits, such as preparing lean and green meals and choosing healthy snacks. Medifast nutritional products are formulated with high-quality ingredients. Medifast’s wholly owned subsidiaries include Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, and OPTAVIA (Singapore) PTE. LTD

Webull offers Medifast Inc stock information, including NYSE: MED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MED stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MED stock methods without spending real money on the virtual paper trading platform.